Amsacrine china manufacture 99.0%min
51264-14-3
2026-06-30
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Product Description
-
Seller Information
-
DescriptionKeywords
Amsacrine
AMSIDINE
M-AMSA, HCL
Quick DetailsProName:Amsacrine china manufacture 99.0%min
CasNo:51264-14-3
Molecular Formula:C21H19N3O3S
Appearance:Orange red crystalline powder
Application:used for medicine
PackAge:packaged according to the needs of customers
Port:china port
ProductionCapacity:Metric Ton/Day
Purity:99.0%min
Storage:Storage at room temperature
Transportation:by sea by air express
LimitNum:1 Kilogram
Superiority99%
DetailsBasic Info-
Product Name:
Amsacrine
Other Name:Methanesulfonamide,N-[4-(9-acridinylamino)-3-methoxyphenyl]-;N-[4-(9-Acridinylamino)-3-methoxyphenyl]methanesulfonamide;4′-(9-Acridinylamino)methanesulfon-m-anisidide;NSC 249992;AMSA;Amsacrine;Acridinylanisidide;NSC 156303;Amsidine;m-Amsacrine;m-AMSA;m-AMSA;SN 21429;Amsidil;Amsidyl;CI 880;SN 11841;Lamasine;Amekrin;Amsalyo;PH 006888
CAS No.:51264-14-3
Molecular Formula:C21H19N3O3S
InChIKeys:InChIKey=XCPGHVQEEXUHNC-UHFFFAOYSA-N
Molecular Weight:393.46
Exact Mass:393.46
EC Number:257-094-3
UNII:00DPD30SOY
NSC Number:249992
DSSTox ID:DTXSID4022604
NCI Thesaurus Code:C240
Color/Form:Yellow crystalline powder
ATC Code:L - Antineoplastic and immunomodulating agents
HScode:2935009090
Categories:
Characteristics-
PSA:
88.7
XLogP3:4
Density:1.4±0.1 g/cm3
Melting Point:230-240 °C
Boiling Point:563°C at 760 mmHg
Flash Point:294.3±32.9 °C
Refractive Index:1.723
Water Solubility:H2O: <1 mg/mL;CHC1 1.0 (mg/mL)
Storage Conditions:Storage site should be as close as practical to lab in which carcinogens are to be used, so that only small quantities required for expt need to be carried. Carcinogens should be kept in only one section of cupboard, an explosion-proof refrigerator or freezer (depending on chemicophysical properties ) that bears appropriate label. An inventory should be kept, showing quantity of carcinogen & date it was acquired Facilities for dispensing should be contiguous to storage area.
Toxicity:Oral-mouse LD50: 53.42 mg/kg; intraperitoneal-mouse LD50: 15.47 mg/kg
Flammability characteristics:Combustible; heat decomposes to release toxic nitrogen oxides and sulfur oxide fumes; drug side effects; nausea, vomiting, bone marrow lesions, etc.
Collision Cross Section:193.1 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Experimental Properties:Mol wt 429.93. Crystals, mp 197-199 °C /Hydrochloride/|Mol wt 489.57. Crystals, mp 292-293 °C /Methanesulfonate/
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
PRECAUTIONS FOR "CARCINOGENS": Storage site should be as close as practical to lab in which carcinogens are to be used, so that only small quantities required for ... expt need to be carried. Carcinogens should be kept in only one section of cupboard, an explosion-proof refrigerator or freezer (depending on chemicophysical properties ...) that bears appropriate label. An inventory ... should be kept, showing quantity of carcinogen & date it was acquired ... Facilities for dispensing ... should be contiguous to storage area. Chemical Carcinogens
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Location:
1613 Guangyin Building,No.42 E.Fengqi Road,Hangzhou,310012 China.
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
7
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
11-50
-
Year of Establishment:
2011
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
